Skip to Content

Haemophilus B Conjugate (Prp-T) Vaccine / Meningococcal Conjugate Vaccine Dosage

Applies to the following strength(s): type C and Y

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

Usual Pediatric Dose for:

Additional dosage information:

Usual Pediatric Dose for Haemophilus influenzae Prophylaxis

0.5 ml intramuscularly at 2, 4, and 6 months of age and a last dose given anywhere from 12 through 15 months of age, for a total of four doses.

The first dose may be given as early as 6 weeks of age. The fourth dose may be given as late as 18 months of age.

Usual Pediatric Dose for Meningococcal Meningitis Prophylaxis

0.5 ml intramuscularly at 2, 4, and 6 months of age and a last dose given anywhere from 12 through 15 months of age, for a total of four doses.

The first dose may be given as early as 6 weeks of age. The fourth dose may be given as late as 18 months of age.

Renal Dose Adjustments

Data not available.

Liver Dose Adjustments

Data not available.

Precautions

Syncope has occurred in association with administration of haemophilus b-meningococcal conjugate vaccine. Syncope can be accompanied by transient neurological signs such as visual disturbance, paresthesia, and tonic-clonic limb movements. Procedures should be in place to avoid falling injury and to restore cerebral perfusion following syncope.

Apnea following intramuscular vaccination has been observed in some infants born prematurely. Decisions about when to administer haemophilus b-meningococcal conjugate vaccine, to infants born prematurely should be based on consideration of the infant's medical status, and the potential benefits and possible risks of vaccination.

Prior to administration of haemophilus b-meningococcal conjugate vaccine, the healthcare provider should review the patient's immunization history for possible vaccine hypersensitivity. Epinephrine and other appropriate agents used for the control of anaphylactic reactions must be immediately available should an acute anaphylactic reaction occur.

Safety and effectiveness of haemophilus b-meningococcal conjugate vaccine in children younger than 6 weeks of age and in children 19 months to 16 years of age have not been established.

Dialysis

Data not available.

Other Comments

Store lyophilized vaccine vials refrigerated at 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit). Diluent may be stored refrigerated or at controlled room temperature between 36 and 77 degrees Fahrenheit (2 to 25 degrees Celsius).

The manufacturer's product information should be consulted for complete reconstitution and administration recommendations.

Hide